Novartis AG (NVS)

Last Price:  

Company Description

Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $48.66B
Net Income (Most Recent Fiscal Year) $8.07B
PE Ratio (Current Year Earnings Estimate) 13.45
PE Ratio (Trailing 12 Months) 13.66
PEG Ratio (Long Term Growth Estimate) 2.09
Price to Sales Ratio (Trailing 12 Months) 3.71
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 3.51
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 10.07
Pre-Tax Margin (Trailing 12 Months) 21.68%
Net Margin (Trailing 12 Months) 19.17%
Return on Equity (Trailing 12 Months) 26.01%
Return on Assets (Trailing 12 Months) 11.11%
Current Ratio (Most Recent Fiscal Quarter) 0.80
Quick Ratio (Most Recent Fiscal Quarter) 0.56
Debt to Common Equity (Most Recent Fiscal Quarter) 0.46
Inventory Turnover (Trailing 12 Months) 2.24
Book Value per Share (Most Recent Fiscal Quarter) $24.76
Earnings per Share (Most Recent Fiscal Quarter) $1.71
Earnings per Share (Most Recent Fiscal Year) $5.75
Diluted Earnings per Share (Trailing 12 Months) $4.33
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 2.24B
Free Float 2.24B
Market Capitalization $189.76B
Average Volume (Last 20 Days) 2.13M
Beta (Past 60 Months) 0.59
Percentage Held By Insiders (Latest Annual Proxy Report) 0.01%
Percentage Held By Institutions (Latest 13F Reports) 9.90%
Annual Dividend (Based on Last Quarter) $2.08
Dividend Yield (Based on Last Quarter) 2.45%